Dasa Cizkova

Has grant

Country flagSlovakia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Study of functional bio-implants and stem cells for CNS regeneration (2016-2020)

Open Date: 2016-01-01

Close Date: 2020-01-01

Grant: Close

Spinal cord repair: releasing the neuron-intrinsic brake on axon regeneration

Open Date: 2016-01-01

Close Date: 2019-01-01

Grant: Close

New combination therapy based on alginate biomaterials and trophic factors for the recovery of the injured spinal cord

Open Date: 2015-01-01

Close Date: 2018-01-01

Grant: Close

BMBS COST Action BM1002 Nanomechanics of intermediate filament networks (NANONET)

Open Date: 2012-01-01

Close Date: 2016-01-01

Grant: Close

Modified biomaterials and cell therapy to support regeneration of injured spinal cord

Open Date: 2012-01-01

Close Date: 2015-01-01

Articles (11)

In recent years, many studies have focused their attention on the dog as a proper animal model for human cancer. In dogs, mammary tumors develop spontaneously, involving a complex interplay between tumor cells and the immune system and revealing several molecular and clinical similarities to human breast cancer. In this review, we summarized the major features of canine mammary tumor, risk factors, and the most important biomarkers used for diagnosis and treatment. Traditional therapy of mammary tumors in dogs includes surgery, which is the first choice, followed by chemotherapy, radiotherapy, or hormonal therapy. However, these therapeutic strategies may not always be sufficient on their own; advancements in understanding cancer mechanisms and the development of innovative treatments offer hope for improved outcomes for oncologic patients. There is still a growing interest in the use of personalized medicine, which should play an irreplaceable role in the research not only in human cancer therapy, but also in veterinary oncology. Moreover, immunotherapy may represent a novel and promising therapeutic option in canine mammary cancers. The study of novel therapeutic approaches is essential for future research in both human and veterinary oncology.

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Michel Salzet

Distuguish Professor (PRCE2)

Ministère de l'Éducation Nationale

FRANCE
View details

Marie Duhamel

Associate professor

Université de Lille

FRANCE
View details

Fabien Vanden Abeele

Université de Lille

FRANCE
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.